Aim Immunotech earnings were -$23.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest AIM earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$3.7M, up 101.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, AIM reported annual earnings of -$29.0M, with 48.9% growth. The next AIM earnings date is Mar 31, 2025.
On AIM's earnings call on Invalid Date, Aim Immunotech (NYSEMKT: AIM) reported Q3 2024 earnings per share (EPS) of -$0.06, up 62.5% year over year. Total AIM earnings for the quarter were -$3.70 million. In the same quarter last year, Aim Immunotech's earnings per share (EPS) was -$0.16.
The next AIM earnings date is Invalid Date. Add AIM to your watchlist to be reminded of Aim Immunotech's next earnings date.
What was AIM's earnings growth in the past year?
As of Aim Immunotech's earnings date in Invalid Date, Aim Immunotech's earnings has grown year over year. AIM earnings in the past year totalled -$23.93 million.
Is Aim Immunotech profitable or losing money?
As of the last Aim Immunotech earnings report, Aim Immunotech is currently losing money. Aim Immunotech's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$23.93 million, a 15.18% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.